ISPC logo

iSpecimen Stock Price

Symbol: NasdaqCM:ISPCMarket Cap: US$4.9mCategory: Healthcare

ISPC Share Price Performance

ISPC Community Fair Values

    Recent ISPC News & Updates

    No updates

    iSpecimen Inc. Key Details

    US$8.1m

    Revenue

    US$5.0m

    Cost of Revenue

    US$3.1m

    Gross Profit

    US$14.4m

    Other Expenses

    -US$11.3m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -2.83
    Gross Margin
    38.45%
    Net Profit Margin
    -139.65%
    Debt/Equity Ratio
    0%

    iSpecimen Inc. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About ISPC

    Founded
    2009
    Employees
    24
    CEO
    Robert Lim
    WebsiteView website
    ispecimen.com

    iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.

    U.S. Market Performance

    • 7 Days: -2.7%
    • 3 Months: 10.1%
    • 1 Year: 17.7%
    • Year to Date: 5.9%
    Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 4.2%. More promisingly, the market is up 17% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading